Trial Profile
Evaluating Duloxetine's Analgesic Effectiveness in Chronic Pelvic Pain
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Pelvic pain
- Focus Therapeutic Use
- 08 Apr 2017 Status changed from active, no longer recruiting to discontinued.
- 02 Apr 2015 Planned End Date changed from 1 Nov 2015 to 1 Dec 2015, as reported by ClinicalTrials.gov.
- 02 Apr 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.